Published in Dermatol Surg on March 01, 2005
Reconstruction of small soft tissue nasal defects. Semin Plast Surg (2013) 0.75
Efficient tumour formation by single human melanoma cells. Nature (2008) 16.35
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. Nat Med (2010) 4.81
Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell (2010) 3.70
Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis. Nat Med (2009) 2.99
Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol (2010) 2.83
Melanoma information on the Internet: often incomplete--a public health opportunity? J Clin Oncol (2002) 2.61
Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat Cell Biol (2006) 2.58
Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model. Ann Surg Oncol (2004) 2.42
The role of sentinel lymph node biopsy for melanoma: evidence assessment. J Am Acad Dermatol (2005) 2.12
Electrosurgery and implantable electronic devices: review and implications for office-based procedures. Dermatol Surg (2011) 2.07
BRAF and NRAS mutations in melanoma and melanocytic nevi. Melanoma Res (2006) 1.85
Connective tissue remodeling induced by carbon dioxide laser resurfacing of photodamaged human skin. Arch Dermatol (2004) 1.85
The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution. Cancer (2009) 1.85
Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer (2007) 1.83
Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology. J Am Acad Dermatol (2011) 1.75
Sunlight, tanning booths, and vitamin D. J Am Acad Dermatol (2005) 1.68
The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma. Cancer (2007) 1.64
Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg (2004) 1.58
Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution. Cancer (2004) 1.50
Treatment of acne vulgaris with a pulsed dye laser: a randomized controlled trial. JAMA (2004) 1.49
Melanoma, version 2.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw (2013) 1.44
Melanoma in middle-aged and older men: a multi-institutional survey study of factors related to tumor thickness. Arch Dermatol (2009) 1.39
Prevalence of psychotropic medication use among cosmetic and medical dermatology patients: a comparative study. J Am Acad Dermatol (2006) 1.38
Atypical fibroxanthoma with lymphomatoid reaction. J Cutan Pathol (2010) 1.38
Melanoma. J Natl Compr Canc Netw (2009) 1.37
Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma. Oncotarget (2012) 1.36
Dermatofibrosarcoma protuberans: how wide should we resect? Ann Surg Oncol (2010) 1.35
Hedgehog-EGFR cooperation response genes determine the oncogenic phenotype of basal cell carcinoma and tumour-initiating pancreatic cancer cells. EMBO Mol Med (2012) 1.27
Patterns of Internet use and impact on patients with melanoma. J Am Acad Dermatol (2005) 1.23
Human melanoma metastasis in NSG mice correlates with clinical outcome in patients. Sci Transl Med (2012) 1.18
Features predicting sentinel lymph node positivity in Merkel cell carcinoma. J Clin Oncol (2011) 1.16
Sentinel Lymph Node Biopsy Use Among Melanoma Patients 75 Years of Age and Older. Ann Surg Oncol (2015) 1.15
Distinct gene expression profiles of viral- and nonviral-associated merkel cell carcinoma revealed by transcriptome analysis. J Invest Dermatol (2012) 1.14
Behavioral determinants of successful early melanoma detection: role of self and physician skin examination. Cancer (2011) 1.14
Efficacy of skin self-examination practices for early melanoma detection. Cancer Epidemiol Biomarkers Prev (2009) 1.12
Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin. Am J Pathol (2007) 1.11
Dermatofibrosarcoma protuberans. J Natl Compr Canc Netw (2012) 1.11
Vulvar melanoma: a report of 20 cases and review of the literature. J Am Acad Dermatol (2004) 1.08
Melanoma, version 4.2014. J Natl Compr Canc Netw (2014) 1.07
A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol (2011) 1.06
Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma. Ann Surg Oncol (2009) 1.04
An education theory-based method to teach a procedural skill. Arch Dermatol (2004) 1.04
Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: a report on 18 patients. Cancer (2003) 1.03
Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2016) 1.02
Thin primary cutaneous melanomas: associated detection patterns, lesion characteristics, and patient characteristics. Cancer (2002) 1.02
EGF gene polymorphism and the risk of incident primary melanoma. Cancer Res (2004) 1.01
Getting patients to the right healthcare sources: from real-world questions to strategy hubs. Proc AMIA Symp (2002) 1.01
Transcriptome profiling identifies HMGA2 as a biomarker of melanoma progression and prognosis. J Invest Dermatol (2013) 1.00
Wide excision without radiation for desmoplastic melanoma. Cancer (2005) 1.00
Dermal matrix remodeling after nonablative laser therapy. J Am Acad Dermatol (2005) 0.96
Mucosal melanoma of the head and neck: predictors of prognosis. Arch Otolaryngol Head Neck Surg (2011) 0.95
BRAF and NRAS mutations in spitzoid melanocytic lesions. Mod Pathol (2006) 0.95
Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma? Cancer (2009) 0.94
Sentinel node biopsy for thin melanomas: which patients should be considered? Cancer Control (2005) 0.94
Validation of statistical predictive models meant to select melanoma patients for sentinel lymph node biopsy. Ann Surg Oncol (2011) 0.94
Gender differences in melanoma awareness and detection practices between middle-aged and older men with melanoma and their female spouses. Arch Dermatol (2009) 0.93
Factors associated with physician discovery of early melanoma in middle-aged and older men. Arch Dermatol (2009) 0.92
Dermatoscopic vascular patterns in cutaneous Merkel cell carcinoma. J Am Acad Dermatol (2011) 0.92
Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. J Am Coll Surg (2005) 0.91
Microstaging accuracy after subtotal incisional biopsy of cutaneous melanoma. J Am Acad Dermatol (2005) 0.91
Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients. Ann Surg Oncol (2014) 0.91
Melanoma. J Natl Compr Canc Netw (2012) 0.90
Merkel cell carcinoma. J Natl Compr Canc Netw (2009) 0.90
Age as a prognostic factor in patients with localized melanoma and regional metastases. Ann Surg Oncol (2013) 0.90
Significance of multiple lymphatic basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy. Ann Surg Oncol (2006) 0.90
Microdermabrasion: a molecular analysis following a single treatment. J Am Acad Dermatol (2005) 0.89
Odontogenic keratocysts arise from quiescent epithelial rests and are associated with deregulated hedgehog signaling in mice and humans. Am J Pathol (2006) 0.88
Basal cell and squamous cell skin cancers. J Natl Compr Canc Netw (2010) 0.88
Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma. Cancer (2011) 0.88
Is a level III dissection necessary for a positive sentinel lymph node in melanoma? J Surg Oncol (2011) 0.87
Copy number variations and clinical outcome in atypical spitz tumors. Am J Surg Pathol (2011) 0.87
Standard immunostains for melanoma in sentinel lymph node specimens: which ones are most useful? J Am Acad Dermatol (2004) 0.86
Internet use and anxiety in people with melanoma and nonmelanoma skin cancer. Dermatol Surg (2011) 0.85
Introduction to flap movement: reconstruction of five similar nasal defects using different flaps. Dermatol Surg (2005) 0.85
Radiotherapy using a water bath in the treatment of Bowen's disease of the digit. Radiother Oncol (2008) 0.85
Microdermabrasion with and without aluminum oxide crystal abrasion: a comparative molecular analysis of dermal remodeling. J Am Acad Dermatol (2006) 0.84
Desmoplastic and neurotropic melanoma. Cancer (2004) 0.84
Clinicopathologic features of primary Merkel cell carcinoma: a detailed descriptive analysis of a large contemporary cohort. Dermatol Surg (2013) 0.83
Clinical recognition, diagnosis, and staging of merkel cell carcinoma, and the role of the multidisciplinary management team. Curr Probl Cancer (2010) 0.83
Melanoma. J Natl Compr Canc Netw (2006) 0.83
Immunostaining for cytokeratin 20 improves detection of micrometastatic Merkel cell carcinoma in sentinel lymph nodes. J Am Acad Dermatol (2002) 0.83
Molecular effects of photodynamic therapy for photoaging. Arch Dermatol (2008) 0.82
Basal cell and squamous cell skin cancers. J Natl Compr Canc Netw (2007) 0.82
Vascular expression of matrix metalloproteinase-13 (collagenase-3) in basal cell carcinoma. Exp Mol Pathol (2003) 0.82
Reliability of sentinel lymph node biopsy for regional staging of head and neck Merkel cell carcinoma. Arch Otolaryngol Head Neck Surg (2005) 0.81
Current management of patients with melanoma who are pregnant, want to get pregnant, or do not want to get pregnant. Cancer (2003) 0.81
Evaluation of staging chest radiographs and serum lactate dehydrogenase for localized melanoma. J Am Acad Dermatol (2004) 0.81
Tretinoin treatment before carbon-dioxide laser resurfacing: a clinical and biochemical analysis. J Am Acad Dermatol (2004) 0.81
Nonsteroidal anti-inflammatory drugs and risk of melanoma. J Skin Cancer (2011) 0.81